Publications by authors named "Pascal Foucher"

Claim this Profile
D
Durable response of lung carcinoma patients to EGFR tyrosine kinase inhibitors is determined by germline polymorphisms in some immune-related genes.
Lorraine Dalens, Julie Niogret, Corentin Richard, Sandy Chevrier, Pascal Foucher

Mol Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial.
Virginie Westeel, Pascal Foucher, Arnaud Scherpereel, Jean Domas, Philippe Girard

Lancet Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncommon EGFR mutations in lung carcinoma: features and treatment outcomes in a retrospective French cohort.
Pierre Tankere, Romain Boidot, Philippe Bonniaud, Ayoube Zouak, Pascal Foucher

J Thorac Dis· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between proton pump inhibitors and severe hematological toxicity in patients receiving pemetrexed-based anticancer treatment: The prospective IPPEM study.
Florian Slimano, Antoine Le Bozec, Amélie Cransac, Pascal Foucher, François Lesauvage

Lung Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does large NGS panel analysed using exome tumour sequencing improve the management of advanced non-small-cell lung cancers?
Julie Niogret, Lorraine Dalens, Caroline Truntzer, Sandy Chevrier, Laure Favier, Pascal Foucher

Lung Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Better survival in impaired renal function patients with metastatic non-small cell lung cancer treated by cisplatin-pemetrexed.
Louis Magali, Foucher Pascal, Aho Serge, Boulin Mathieu, Zouak Ayoube

Eur J Clin Pharmacol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Patients With Advanced NSCLC From the Intergroupe Francophone de Cancérologie Thoracique Biomarkers France Study by Mutation Subtypes.
Anne-Marie Ruppert, Michèle Beau-Faller, Didier Debieuvre, L'Houcine Ouafik, Virginie Westeel, Pascal Foucher

JTO Clin Res Rep· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Could venous thromboembolism and major bleeding be indicators of lung cancer mortality? A nationwide database study.
Jennifer Howlett, Eric Benzenine, Jonathan Cottenet, Pascal Foucher, Philippe Fagnoni

BMC Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation and use of whole exome sequencing for metastatic solid cancer.
Manon Réda, Corentin Richard, Aurelie Bertaut, Julie Niogret, Thomas Collot, Pascal Foucher

EBioMedicine· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Staging of nutrition disorders in non-small-cell lung cancer patients: utility of skeletal muscle mass assessment.
Sami Antoun, Hugues Morel, Pierre-Jean Souquet, Veerle Surmont, David Planchard, Pascal Foucher

J Cachexia Sarcopenia Muscle· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy.
Jean-David Fumet, Corentin Richard, Fanny Ledys, Quentin Klopfenstein, Philippe Joubert, Pascal Foucher

Br J Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo).
Balazs Halmos, Eng-Huat Tan, Ross A Soo, Jacques Cadranel, Min Ki Lee, Pascal Foucher

Lung Cancer· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy.
Jean-David Fumet, Corentin Richard, Fanny Ledys, Quentin Klopfenstein, Philippe Joubert, Pascal Foucher

Br J Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between lung cancer somatic mutations and occupational exposure in never-smokers.
Christophe Paris, Pascal Do, Bénédicte Mastroianni, Adrien Dixmier, Patrick Dumont, Pascal Foucher

Eur Respir J· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotic Use Does Not Appear to Influence Response to Nivolumab.
Coureche Kaderbhai, Corentin Richard, Jean David Fumet, Anne Aarnink, Pascal Foucher

Anticancer Res· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to first line chemotherapy regimen is associated with efficacy of nivolumab in non-small-cell lung cancer.
Courèche-Guillaume Kaderbhai, Corentin Richard, Jean David Fumet, Anne Aarnink, Sandra Ortiz-Cuaran, Pascal Foucher

Oncoimmunology· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers.
Sébastien Couraud, Pierre-Jean Souquet, Christophe Paris, Pascal Dô, Hélène Doubre, Pascal Foucher

Eur Respir J· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free DNA in lung cancer from never-smokers: a proof-of-concept study from BioCAST/IFCT-1002.
Sébastien Couraud, Felipe Vaca-Paniagua, Stéphanie Villar, Javier Oliver, Tibor Schuster, Pascal Foucher

Clin Cancer Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pleuroparenchymal fibroelastosis as a late complication of chemotherapy agents.
Caroline Beynat-Mouterde, Guillaume Beltramo, Guillaume Lezmi, Didier Pernet, Clio Camus, Pascal Foucher

Eur Respir J· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2).
Jacques Cadranel, Audrey Mauguen, Michele Faller, Gérard Zalcman, Marie-Pierre Buisine, Pascal Foucher

J Thorac Oncol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxic dendritic cells generated from cancer patients.
Daniela Lakomy, Nona Janikashvili, Jennifer Fraszczak, Malika Trad, Sylvain Audia, Pascal Foucher

J Immunol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Tracheobronchopathia osteochondroplastica revealed by hemoptysis in a smoker patient].
Maxime Samson, Ahmad Jibbaoui, Pascal Foucher, Mathilde Funes de la Vega, Philippe Camus

Presse Med· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interstitial lung disease induced by drugs and radiation.
Philippe Camus, Annlyse Fanton, Philippe Bonniaud, Clio Camus, Pascal Foucher

Respiration· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-induced and iatrogenic infiltrative lung disease.
Philippe Camus, Philippe Bonniaud, Annlyse Fanton, Clio Camus, Nicolas Baudaun, Pascal Foucher

Clin Chest Med· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer.
Alain Depierre, Bernard Milleron, Denis Moro-Sibilot, Sylvie Chevret, Elisabeth Quoix, Pascal Foucher

J Clin Oncol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis